Solid Biosciences Inc. (SLDB)

Solid Biosciences Inc. (SLDB) is a healthcare company (biotechnology) based in the United States. The share price is $6.34, down 2.16% on the day, which values the company at $707.61M. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$6.34−2.16% today
Market value
$707.61M
200-week average
$6.192% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Solid Biosciences Inc. in more detail

SLDB trades at -4.0× next year's expected earnings. It sits 2% above its 200-week average of $6.19.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold SLDB, including Peter Kolchinsky (1.0% of the portfolio).

Superinvestors holding SLDB

1 of the investors tracked here report a position in their latest 13F filing.

Solid Biosciences Inc. (SLDB): questions and answers

What is Solid Biosciences Inc.'s market cap?

Solid Biosciences Inc. is valued at $707.61M at a share price of $6.34.

Is SLDB above its 200-week moving average?

Yes. SLDB is 2.4% above its 200-week average of $6.19. Long-term investors watch that line because strong companies rarely trade below it for long.

Does SLDB pay a dividend?

Solid Biosciences Inc. does not currently pay a regular dividend.

Which famous investors own SLDB?

In their latest quarterly filings, Peter Kolchinsky (1.0% of the portfolio) hold SLDB. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Solid Biosciences Inc. (SLDB) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SLDB

Underlying data: Yahoo Finance; company filings with the SEC.